Myopic choroidal neovascularization (CNV) is one of the leading causes of visual
impairment worldwide. The clinical and socioeconomic impact of myopic CNV in Asian …

Choroidal neovascularisation (CNV) is a common vision-threatening complication of myopia
and pathological myopia. Despite significant advances in understanding the epidemiology …

Pathological myopia is a major cause of irreversible vision loss and is the fourth to ninth
most frequent cause of blindness in the world. Choroidal neovascularization (CNV) …

PURPOSE: To assess the potential effect of intravitreal bevacizumab (IVB)(Avastin;
Genentech, South San Francisco, California, USA) on retinal function and anatomic recovery …

The first effective therapy for exudative macular degeneration (AMD) was Photodynamic
Therapy (PDT). Diagnosis of the disease was to a large extent by fluorescein angiography …

Background: Pathologic myopia is the second cause of choroidal neovascularization, after
age-related macular degeneration (AMD), and the first cause in patients younger than 50 …

PURPOSE: To evaluate the safety and efficacy of intravitreal bevacizumab in the treatment
of choroidal neovascularization (CNV) secondary to pathologic myopia (PM). DESIGN …

Background Myopic macular degeneration (MMD) is a primary cause of blindness and
visual impairment in many parts of the world. A review of clinical practice guidelines (CPGs) …

Choroidal neovascularization is a common cause of vision loss in patients with pathologic
myopia, often resulting in irreversible central vision loss. This is particularly important …

Choroidal neovascularisation (CNV) secondary to pathological myopia is an important
cause of significant visual impairment in young and middle aged adults globally and is …